| Nicholas A Sannella, MD | |
|
7 Warwick Cir, Andover, MA 01810-2573 | |
| (978) 470-2602 | |
| Not Available |
| Full Name | Nicholas A Sannella |
|---|---|
| Gender | Male |
| Speciality | Surgery - Vascular Surgery |
| Location | 7 Warwick Cir, Andover, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003937152 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 34589 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas A Sannella, MD 7 Warwick Cir, Andover, MA 01810-2573 Ph: (978) 470-2602 | Nicholas A Sannella, MD 7 Warwick Cir, Andover, MA 01810-2573 Ph: (978) 470-2602 |
News Archive
A protein that protects some of our immune cells from the most common and virulent form of HIV works by starving the virus of the molecular building blocks that it needs to replicate, according to research published online in Nature Immunology.
The age-old fascination with machines mimicking humans has frequently manifested itself in science fiction literature and cinema, mainly because authors and directors could only wildly speculate about these "human robots" since none had been built yet. According to bionic limb experts at IEEE, the world's largest professional technical association, the distinction between science fiction and reality is increasingly becoming blurred.
A molecule widely believed to fight many forms of cancer actually helps deadly thyroid tumors grow, and cancer therapies now being tested in humans might boost the activity of this newly revealed bad guy, researchers at Mayo Clinic in Florida say.
Enzon Pharmaceuticals, Inc. today announced the Investigational New Drug (IND) approval by the US Food and Drug Administration (FDA) and plan to commence enrollment into a Phase 1a/1b study shortly. The study will evaluate the safety and tolerability of EZN-4176, the company's novel androgen receptor (AR) mRNA antagonist, for the treatment of patients with castration-resistant prostate cancer (CRPC).
AstraZeneca and EvoRx Technologies successfully completed a one-year research collaboration leveraging EvoRx's proprietary Evo-Link technology to discover cell penetrating peptides for a high value intracellular protein–protein interaction target in the respiratory portfolio.
› Verified 5 days ago
Nancy C Landay, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Andover Surgical Assoc., 140 Haverhill Street, Andover, MA 01810 Phone: 978-475-4202 | |
Kaitlan Ahrens, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 323 Lowell St Ste 302, Andover, MA 01810 Phone: 978-475-4202 | |
Dr. Kyle Peter Harvey, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 140 Haverhill Street, Andover, MA 01810 Phone: 978-475-4202 Fax: 978-475-4393 | |
Earl R Gonzales, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 140 Haverhill St, Andover, MA 01810 Phone: 978-475-4202 Fax: 978-475-4393 | |
Jonathan D Mandell, M.D. Surgery Medicare: Medicare Enrolled Practice Location: Andover Surgical Assoc, 140 Haverhill Street, Andover, MA 01810 Phone: 978-475-4202 | |
Paul J Gemis, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 140 Haverhill St, Andover, MA 01810 Phone: 978-475-4202 |